These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7736717)

  • 21. [Blood - surely but safely!].
    Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):905-6. PubMed ID: 22842882
    [No Abstract]   [Full Text] [Related]  

  • 22. Bacterial contamination of blood products.
    Palavecino E; Jacobs M; Yomtovian R
    Curr Hematol Rep; 2004 Nov; 3(6):450-5. PubMed ID: 15496280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving transfusion practice with guidelines and prospective auditing by medical laboratory technologists.
    Lin Y; Cserti-Gazdewich C; Lieberman L; Pendergrast J; Rammler W; Skinner I; Callum J
    Transfusion; 2016 Nov; 56(11):2903-2905. PubMed ID: 28211959
    [No Abstract]   [Full Text] [Related]  

  • 24. [Quality of transfusion means and protocols of massive transfusions].
    Zhiburt EB; Vergopulo AA; Kopchenko TG; Gubanova MN
    Vestn Khir Im I I Grek; 2009; 168(2):75-7. PubMed ID: 19514398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When, why and how to order blood?
    Steenssens L
    Acta Anaesthesiol Belg; 2003; 54(4):313-4. PubMed ID: 14719351
    [No Abstract]   [Full Text] [Related]  

  • 26. Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences.
    Shulman IA; Jones FS
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S17-22. PubMed ID: 9124224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet Symposium: Recent developments in British Blood Transfusion Service and clinical practice. Proceedings. London, 8 April 1992.
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):615-62. PubMed ID: 1450326
    [No Abstract]   [Full Text] [Related]  

  • 28. International blood collection and storage: clinical use of blood products.
    Greening DW; Glenister KM; Sparrow RL; Simpson RJ
    J Proteomics; 2010 Jan; 73(3):386-95. PubMed ID: 19664733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The responsibility of the physician prescriber of blood products].
    Hergon E; Quaranta JF; Moutel G; Hervé C; Rouger P
    Transfus Clin Biol; 2004 Oct; 11(4):221-7. PubMed ID: 15564105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recommendations for rationally-based hemotherapy].
    Welte M; Hachenberg T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):184-5. PubMed ID: 19266419
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternatives to standard blood transfusion: availability and promise.
    Prowse CV
    Transfus Med; 1999 Dec; 9(4):287-99. PubMed ID: 10583882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The provision of safe blood--policy issues in the prevention of human immunodeficiency virus transmission.
    van Dam CJ; Sondag-Thull D; Fransen L
    Trop Doct; 1992 Jan; 22(1):20-3. PubMed ID: 1542943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of whole blood usage in massive transfusion.
    Reeves-Viets JL; Yawn DH
    Nurse Anesth; 1991 Dec; 2(4):184-7. PubMed ID: 1751574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety monitoring and epidemiological surveillance of blood transfusion in the United States.
    Menache D; O'Malley JP
    Transfus Clin Biol; 1995; 2(1):7-12. PubMed ID: 7728271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making sense of the use of blood and blood products.
    Dodsworth H
    Nurs Times; 1995 Jan 4-11; 91(1):25-7. PubMed ID: 7838744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Production and consumption of blood and blood products in Norway. Factors of quality assurance in transfusion medicine].
    Heier HE
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):18-22. PubMed ID: 8424244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Labile blood product traceability: definition, regulation, evaluation, and perspectives].
    Pélissier E; Nguyen L
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():72s-74s. PubMed ID: 10919229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current good manufacturing practices.
    Zuck TF
    Transfusion; 1995; 35(11):955-66. PubMed ID: 8604495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.